The share of corresponding/leading authors in biomedical engineering publications in China shows a consistent yet slight decline from 2024 at 98.15% to 2028 at 98.12%, indicating a very stable trend. Given 2023's actual data slightly below 98.15%, the year-on-year decrease is extremely marginal. This steadiness suggests that the proportion of leading authors is entrenched in a highly consistent pattern with minimal annual change. The compound annual growth rate (CAGR) over this forecast period also reflects negligible fluctuation.
Future trends to watch include potential shifts in international collaborations, increased diversity of the author base, and the evolving landscape of AI in research contribution, potentially affecting authorship dynamics.
